Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Sánchez-Cuerda C, Cuadra M, Gámir S, Lobo P, Elices M, Cabrera Y.
Int J Gynaecol Obstet. 2022 Jul;158(1):21-26. doi: 10.1002/ijgo.13948. Epub 2021 Oct 23.
Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.
Teoh D, Musa F, Salani R, Huh W, Jimenez E.
Obstet Gynecol. 2020 Apr;135(4):869-878. doi: 10.1097/AOG.0000000000003761.
Adenocarcinoma in situ of the uterine cervix: Clinical practice guidelines from the Italian society of colposcopy and cervical pathology (SICPCV).
Ciavattini A, Giannella L, Delli Carpini G, Tsiroglou D, Sopracordevole F, Chiossi G, Di Giuseppe J; Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV).
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:273-277. doi: 10.1016/j.ejogrb.2019.07.014. Epub 2019 Jul 20.
Conservative Treatment for Cervical Adenocarcinoma In Situ: Long-Term Results.
Monti E, Somigliana E, Alberico D, Boero V, Iorio M, Di Loreto E, Dell'acqua A, Liverani CA.
J Low Genit Tract Dis. 2022 Oct 1;26(4):293-297. doi: 10.1097/LGT.0000000000000688. Epub 2022 Aug 3.
Cervical adenocarcinoma in situ.
Hopkins MP, Roberts JA, Schmidt RW.
Obstet Gynecol. 1988 Jun;71(6 Pt 1):842-4.
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group.
Int J Cancer. 2020 Feb 1;146(3):810-818. doi: 10.1002/ijc.32340. Epub 2019 May 6.
Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease.
Krivak TC, Rose GS, McBroom JW, Carlson JW, Winter WE 3rd, Kost ER.
Obstet Gynecol Surv. 2001 Sep;56(9):567-75. doi: 10.1097/00006254-200109000-00023.
Adenocarcinoma in situ or early-stage cervical cancer is a risk factor for preterm delivery after cervical conization: a multicenter observational study.
Kasuga Y, Ikenoue S, Nishio H, Yamagami W, Ochiai D, Tanabe K, Tashima Y, Hirao N, Miyakoshi K, Kasai K, Suda Y, Nemoto T, Shiraishi S, Yoshida H, Kurahashi T, Takamatsu K, Iwasaki S, Yamashita H, Akiba Y, Arase T, Hara S, Nakada S, Tanaka M, Aoki D.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9837-9842. doi: 10.1080/14767058.2022.2056835. Epub 2022 Mar 27.
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.
Lehtinen M, Gray P, Luostarinen T, Eriksson T, Apter D, Bly A, Harjula K, Heikkilä K, Hokkanen M, Kuortti M, Nieminen P, Nummela M, Paavonen J, Palmroth J, Petäjä T, Pimenoff VN, Pukkala E, Dillner J.
Front Cell Infect Microbiol. 2024 Sep 9;14:1437704. doi: 10.3389/fcimb.2024.1437704. eCollection 2024.
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.
Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT.
Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015.
